Skip to main content
Dr. Miltie  |  Clinical technology for care wherever it happens. Need funding? Explore Atlas by Dr. Miltie (opens in a new tab)
•Blog

Remote Monitoring, Proactive Care and the Promise of Digital Health

Digital Health

Historical context and evidence update (November 3, 2026)

This article preserves Eric Venn-Watson’s July 30, 2015 perspective on digital health. Its forecasts and descriptions of what remote patient monitoring (RPM) could accomplish reflect that period, rather than guarantees of current clinical outcomes. RPM involves connected devices transmitting selected physiologic measurements for a care team to review and use in treatment management; data collection alone is not a diagnosis or a promise of timely intervention.

Later evidence varies by condition, intervention and outcome. A 2024 systematic review and meta-analysis of telemedicine support for heart failure reported reductions in heart-failure-related hospitalizations and all-cause mortality in studied programs, but no statistically significant reduction in all-cause hospitalizations. Those findings do not automatically apply to asthma, diabetes or every RPM device; cost savings and prevention of acute events are not assured.

Sources: CMS remote patient monitoring overview; 2024 systematic review and meta-analysis of heart-failure telemedicine.

Real-time access to selected vital signs may support chronic care management and value-based care when measurements are reviewed and acted on by clinicians.

By Eric Venn-Watson, July 30, 2015.

The Goldman Sachs report referenced in the first part of this series described remote patient monitoring (RPM) as a possible tool for supporting care of higher-risk patients, while treating spending reductions as potential rather than established outcomes. The report’s 2015 discussion highlighted heart disease, asthma and diabetes as possible areas for digital health innovation; it did not establish that RPM would produce the same results across these conditions.

Remote monitoring was seen in 2015 as a promising area of healthcare innovation, but its value depends on the patient population, intervention and clinical follow-up. For people with congestive heart failure (CHF), connected monitoring can relay selected measurements to clinical teams and may support earlier responses to deterioration; reduced readmissions are not assured in every program. For people with asthma, some tools may track selected respiratory measures or environmental triggers, but reliable alerts and patient benefits depend on the device, care plan and clinical response. For people with diabetes, continuous glucose monitoring can support glucose management, although it does not replace a comprehensive clinical assessment or ongoing follow-up.

One approach to RPM combines connected measurements with relevant health history, analytics and clinical decision support, potentially notifying patients and care teams when measurements cross predefined thresholds. Such data and alerts may help identify concerning changes earlier and support clinical decisions, but they cannot reliably predict or prevent every acute event. These technologies may support more proactive care when trained clinical teams can review the information and respond appropriately.

Ultimately, clinicians want to provide the best care possible and make a positive impact on our patients’ quality of life. Digital tools can help clinical teams use patient data to inform decisions, but their effect on outcomes and workflows depends on integration, accessibility, staffing and implementation. The old ways of doing business are no longer acceptable. The new financial and regulatory models won’t allow for it – and ultimately, the patients won’t stand for it.

The digital healthcare revolution has arrived.

Move from information to action

See how the N9+ can fit your organization.

Explore the remote physical exam platform or request a focused demonstration.